RT Journal Article
SR Electronic
T1 High but Short-lived anti-SARS-CoV2 neutralizing, IgM, IgA, and IgG levels among mRNA-vaccinees compared to naturally-infected participants
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.05.08.22274817
DO 10.1101/2022.05.08.22274817
A1 Abou-Saleh, Haissam
A1 Abo-Halawa, Bushra Y.
A1 Younes, Salma
A1 Younes, Nadin
A1 Al-Sadeq, Duaa W.
A1 Shurrab, Farah M.
A1 Liu, Na
A1 Qotba, Hamda
A1 Al-Dewik, Nader
A1 Ismail, Ahmad H.
A1 Yassine, Hadi M.
A1 Abu-Raddad, Laith J.
A1 Nasrallah, Gheyath K.
YR 2022
UL http://medrxiv.org/content/early/2022/05/10/2022.05.08.22274817.abstract
AB Background Waning of protection against emerging SARS-CoV-2 variants by pre-existing antibodies elicited due to current vaccination or natural infection is a global concern. Whether this is due to waning of immunity to SARS-COV-2 remains unclear.Aim We aimed to investigate dynamics of antibody isotype responses among vaccinated naïve (VN) and naturally infected (NI) individuals.Methods We followed up antibody levels in COVID-19 mRNA-vaccinated subjects without prior infection (VN, n=100) at two phases: phase-I (P-I) at ∼1.4 and phase-II (P-II) at ∼5.3 months. Antibody levels were compared to those of unvaccinated and naturally infected subjects (NI, n=40) at ∼1.7 (P-1) and 5.2 (P-II) months post-infection. Neutralizing antibodies (NTAb), anti-S-RBD-IgG, -IgM, and anti-S-IgA isotypes were measured.Results VN group produced significantly greater antibody responses (p<0.001) than NI group at P-I except for IgM. In VN group, a significant waning in antibody response was observed in all isotypes. There was about ∼ a 4-fold decline in NTAb levels (p<0.001), anti-S-RBD-IgG (∼5-folds, p<0.001), anti-S-RBD-IgM (∼6-folds, p<0.001), and anti-S1-IgA (2-folds, p<0.001). In NI group, a significant but less steady decline was notable in NTAb (∼1-folds, p<0.001), anti-S-RBD IgG (∼1-fold, p=0.005), and S-RBD-IgM (∼2-folds, p<0.001). Unlike VN group, NI group mounted a lasting anti-S1-IgA response with no significant decline. Anti-S1-IgA levels which were ∼3 folds higher in VN subjects compared to NI in P-1 (p<0.001), dropped to almost same levels, with no significant difference observed between the two groups in P-II.Conclusion While double dose mRNA vaccination boosted antibody levels, this “boost” was relatively short-lived in vaccinated individuals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was made possible by grant number UREP28-173-3-057 from the Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the authors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was reviewed and approved by the Institutional Review Board at Qatar University (QU-IRB 1537-FBA/21).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors